Volume 20, Issue 6 (9-2017)                   J Arak Uni Med Sci 2017, 20(6): 22-30 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khoshbin Nazdik M, Khazaei Koohpar Z, Sayad A. Investigation of TIMP-1 Gene Expression in Patients with Multiple Sclerosis(MS). J Arak Uni Med Sci. 2017; 20 (6) :22-30
URL: http://amuj.arakmu.ac.ir/article-1-4972-en.html
Asistant Professor, PhD in Cellular and Molecular Biology, Department of Cellular and Molecular Biology, Faculty of Biological Sciences,Tonekabon Branch, Islamic Azad University, Tonekabon, Iran. , khazaei@toniau.ac.ir
Abstract:   (1818 Views)
Abstract
Background: Matrix metalloproteinases (MMPs) comprise a family of proteolytic enzymes.MMPs are capable of disrupting the blood-brain barrier (BBB), mediating the destruction of extracellular matrix and myelin components. Tissue inhibitors of metalloproteinases (TIMPs) are proteins which block the activitiy of MMPs. Matrix metalloproteinase-9 (MMP-9) facilitates T-cell migration into the CNS while the tissue inhibitor matrix metalloproteinase-1 (TIMP-1) inhibits MMP-9 actions. The aim of this study was to evaluate the expression of TIMP-1 gene (in RNA level) in blood cells of relapsing-remitting multiple sclerosis (RRMS) patients treated with IFNb.
Materials and Methods: In this study, the expression level of TIMP-1 gene was investigated in blood cells of MS patients compared to healthy subjects by Real-Time PCR.
Results: The RRMS patients manifested a lower expression level of TIMP-1 RNA than their normal counterparts, although the result was not significant (p=0.1).
Conclusion: The results of this study showed that there was no linear correlation between TIMP-1 expression level and risk of Expanded Disability Status Scale of Kurtzke (EDSS); nor was there any significant correlation between expression status of TIMP-1 and duration of the disease. Further studies are recommended to compare TIMP-1 RNA in patients before and after taking IFN-beta.
Full-Text [PDF 900 kb]   (354 Downloads)    
Type of Study: Original Atricle | Subject: Basic Sciences
Received: 2017/03/3 | Accepted: 2017/07/19 | Published: 2017/08/20

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


© 2018 All Rights Reserved | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb